A comprehensive view of Inflammations. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Dragonfly Therapeutics announces sixth Dragonfly TriNKET immunotherapy drug candidate opt-in by Bristol Myers; the two firms have collaborated on hematology malignancies, oncology, neuroinflammation targets
Published: January 09, 2023 by ENP Newswire
Scientific review finds culinary herb, spice consumption may exert a prebiotic effect, positively modulating gut microbes; polyphenols in herbs, spices may play an important role in inflammation related afflictions such as obesity
Published: January 06, 2023 by Food Chemistry
Health Canada grants clearance for clinical trial of Ceapro's pharmaceutical-grade oral avenanthramide anti-inflammatory therapy
Published: December 28, 2022 by MarketLine
Pfizer, Roivant form new subsidiary to develop and commercialize Roivant’s drug candidates for treating inflammatory diseases and fibrosis; operation will develop Roivant’s RVT-3101, a fully human monoclonal antibody to treat ulcerative colitis
Published: December 22, 2022 by Indian Pharma Industry: Policies
Pfizer announces FDA has accepted for review a New Drug Application for oral etrasimod in individuals with moderately-to-severely active ulcerative colitis; final decision is expected in H2 2023
Published: December 21, 2022 by Business Wire

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count